ENDEFR
Home › Switzerland › AMAL THERAPEUTICS SA

AMAL THERAPEUTICS SA

Aktiengesellschaft (AG) · Genève, Switzerland · LEI 52990091QOK2WBQB9Q20
LEI active

Summary

AMAL THERAPEUTICS SA is registered in Switzerland and entered in the “Commercial Register” under number CHE270837659. Its legal form is Aktiengesellschaft (AG) – public limited company (Switzerland). According to GLEIF, its ultimate parent is C.H. Boehringer Sohn AG & Co. KG (Germany), which is also its direct parent. That group has 41 subsidiaries with LEIs in 16 countries, 2 of them in Switzerland. The LEI was first issued on 27 Aug 2024 and the record was last updated on 3 Jul 2026; the next renewal is due by 27 Aug 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formAktiengesellschaft (AG)
public limited company (Switzerland)
RegisterCommercial Register · Register website
Registration numberCHE270837659
Registration authorityMinistry of Justice
JurisdictionSwitzerland
Registered addressavenue de la Roseraie 64, 1205 Genève, Switzerland
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)3 Sep 2012
LEI52990091QOK2WBQB9Q20
LEI statusactive
LEI first issued27 Aug 2024
LEI record last updated3 Jul 2026
Next LEI renewal27 Aug 2027
Corroboration of the LEI recordfully corroborated

Group membership

C.H. Boehringer Sohn AG & Co. KG Germany ultimate parent
AMAL THERAPEUTICS SA this entity
View the whole group: 41 subsidiaries in 16 countries

Relationship to the parent

Direct parentUltimate parent
ParentC.H. Boehringer Sohn AG & Co. KGC.H. Boehringer Sohn AG & Co. KG
Accounting period1 Jan 2024 to 31 Dec 20241 Jan 2024 to 31 Dec 2024
Evidenceconsolidated accountsconsolidated accounts
Corroborationfully corroboratedfully corroborated
Relationship start27 Aug 202427 Aug 2024
Recorded at GLEIF since27 Aug 202427 Aug 2024
Last updated3 Jul 20263 Jul 2026
Record statuscurrentcurrent

Other subsidiaries of the same direct parent (40)

and 28 more